540 related articles for article (PubMed ID: 25510389)
1. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
2. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
3. The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.
van Rijn PA; Maris-Veldhuis MA; van Gennip RGP
Viruses; 2021 May; 13(5):. PubMed ID: 34067226
[TBL] [Abstract][Full Text] [Related]
4. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
5. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
[TBL] [Abstract][Full Text] [Related]
7. Development of a competitive ELISA for NS3 antibodies as DIVA test accompanying the novel Disabled Infectious Single Animal (DISA) vaccine for Bluetongue.
Tacken MGJ; Daus FJ; Feenstra F; van Gennip RGP; van Rijn PA
Vaccine; 2015 Oct; 33(42):5539-5545. PubMed ID: 26387435
[TBL] [Abstract][Full Text] [Related]
8. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.
van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA
PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753
[TBL] [Abstract][Full Text] [Related]
9. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
10. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
[TBL] [Abstract][Full Text] [Related]
11. Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
van Rijn PA; Daus FJ; Maris-Veldhuis MA; Feenstra F; van Gennip RGP
Vaccine; 2017 Jan; 35(2):231-237. PubMed ID: 27916409
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
Zulu GB; Venter EH
J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
[TBL] [Abstract][Full Text] [Related]
14. VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-/-) mice.
Marín-López A; Otero-Romero I; de la Poza F; Menaya-Vargas R; Calvo-Pinilla E; Benavente J; Martínez-Costas JM; Ortego J
Antiviral Res; 2014 Oct; 110():42-51. PubMed ID: 25057758
[TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
Kochinger S; Renevey N; Hofmann MA; Zimmer G
Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.
Mohamed DKA; Du J; Gao S; Tian Z; Zhang G; Huang D; Du R; Kang B; Liu G; Luo J; Yin H
Vet Microbiol; 2018 Jun; 219():40-48. PubMed ID: 29778203
[TBL] [Abstract][Full Text] [Related]
17. Recombinant bluetongue virus with hemagglutinin epitopes in VP2 has potential as a labeled vaccine.
Guo Y; Huang L; Bi K; Xu Q; Bu Z; Wang F; Sun E
Vet Microbiol; 2020 Sep; 248():108825. PubMed ID: 32891953
[TBL] [Abstract][Full Text] [Related]
18. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
[TBL] [Abstract][Full Text] [Related]
19. Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.
Feenstra F; Drolet BS; Boonstra J; van Rijn PA
Parasit Vectors; 2015 Sep; 8():476. PubMed ID: 26383094
[TBL] [Abstract][Full Text] [Related]
20. Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virus.
Marín-López A; Calvo-Pinilla E; Barriales D; Lorenzo G; Benavente J; Brun A; Martínez-Costas JM; Ortego J
Antiviral Res; 2017 Jun; 142():55-62. PubMed ID: 28322923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]